An editorial with some interest for the cardiothoracic surgeon, in particular the awareness of changes in the right vantricle during ECMO support , mostly drawn from the recent Covid experiences, and with a useful paragraph on veno-pulmonary arterial ECMO, discussing the uncoupling of RV and PA.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Intensive Care
January 21, 2022
October 1, 2021
A scholarly narrative on the utility of quantifying the performance of the right ventricle: the RV has been hitherto empirically assessed in many clinical setups.
July 12, 2021
In this article, Jacobs et al. provide a multi-institutional outcomes review of 200 consecutive patients with confirmed COVID-19 supported with ECMO. The mean time on ECMO was 15 days with survival on VV-ECMO of 46.3% and survival on VA-ECMO of 25%.
April 16, 2021
A most comprehensive practice guideline, relevant not only to surgeons involved in VA ECMO, but also all cardiac and thoracic colleagues and perioperative clinicians.
February 21, 2021
In this article by the COVEC Study Group, they conducted a EuroELSO international survey investigating the clinical outcomes of extracorporeal membrane oxygenation (ECMO) on patients with COVID-19 Acute Respiratory Distress Syndrome (ARDS).
January 16, 2021
A recent European consensus paper. Relatively easily read, and favouring meta-analyses over randomised trials. The bulk of the manuscript is of interest to all healthcare providers. The chapters 2.8.1 and 3.1.2 are of additional relevance to the ctsnet readership, as they summarise guidance on interventions.
August 18, 2020
A review that may affect pharma strategy in the immediate future.
May 15, 2020
A medium-sized RCT from the Imperial College. The research question are of interest for all cardiovascular, thoracic, and general surgeons as well as all healthcare professionals.
May 6, 2020
This article describes recommendations from the North American leadership in regards to the safe reintroduction of cardiovascular services during the COVID-19 pandemic including, but not limited to, ethical considerations, the importance of collaboration amongst public health officials and cardiovascular specialties, and protection of healthcare work
April 16, 2020
The UNOS donor heart allocation system was revised in 2018, giving priority to patients on inpatient mechanical circulatory support (MCS). Patients admitted with heart failure-associated cardiogenic shock were tracked for the frequency of use of mechanical circulatory support before and after implementation of this change. In non-transplant center